Paramount BioCapital Asset Management logo

Paramount BioCapital Asset Management

North America, New York, United States, New York

Description

Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new

Investor Profile

Paramount BioCapital Asset Management has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Post Ipo Equity (60%)
  • Series Unknown (40%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Genetics
  • Oncology
  • Biopharma
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Paramount BioCapital Asset Management frequently co-invest with?

ProQuest Investments
North America, New Jersey, United States, Princeton
Co-Investments: 1
LG
North America, Texas, United States, Dallas
Co-Investments: 1
Henderson Global Investors
Europe, England, United Kingdom, London
Co-Investments: 1
MB
North America, New York, United States, New York
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
FM
North America, California, United States, San Francisco
Co-Investments: 1
PA
North America, Illinois, United States, Chicago
Co-Investments: 1
CA
North America, New York, United States, New York
Co-Investments: 1
Cycad Group
North America, California, United States, Santa Barbara
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Paramount BioCapital Asset Management?

CEL-SCI

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 20, 2009
Amount Raised: $4,400,000
Innovive Pharmaceuticals

New York, New York, United States

Innovive Pharmaceuticals is a development stage company.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 25, 2007
Amount Raised: $15,000,000
Genelabs Technologies

Redwood City, California, United States

Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownJun 27, 2006
Amount Raised: $8,300,000
Alaunos Therapeutics

New York, New York, United States

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.

BiotechnologyGeneticsOncologyPharmaceuticalTherapeutics
Post Ipo EquityMay 3, 2006
Amount Raised: $37,000,000
Chelsea Therapeutics International

Charlotte, North Carolina, United States

Chelsea Therapeutics International is a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJan 12, 2005
Amount Raised: $14,500,000